124 related articles for article (PubMed ID: 24128721)
1. In response.
Mascalchi M; Lopes-Pegna A; Paci E
J Thorac Oncol; 2013 Nov; 8(11):e102-3. PubMed ID: 24128721
[No Abstract] [Full Text] [Related]
2. Overdiagnosis in lung cancer screening with low-dose computed tomography.
Takiguchi Y; Sekine I; Iwasawa S
J Thorac Oncol; 2013 Nov; 8(11):e101-2. PubMed ID: 24128720
[No Abstract] [Full Text] [Related]
3. Screening-detected lung cancers: is systematic nodal dissection always essential?
Veronesi G; Maisonneuve P; Pelosi G; Casiraghi M; Agoglia BG; Borri A; Travaini LL; Bellomi M; Rampinelli C; Brambilla D; Bertolotti R; Spaggiari L
J Thorac Oncol; 2011 Mar; 6(3):525-30. PubMed ID: 21289523
[TBL] [Abstract][Full Text] [Related]
4. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
5. Contrasting Management of Small Cell Lung Cancer and Non-Small Cell Lung Cancer: Emerging Data for Low-Dose Computed Tomography Screening.
Murray N; Lam S
J Thorac Oncol; 2016 Feb; 11(2):139-41. PubMed ID: 26811224
[No Abstract] [Full Text] [Related]
6. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Wang Y; Ma S; Dong M; Yao Y; Liu K; Zhou J
BMC Pulm Med; 2015 Mar; 15():20. PubMed ID: 25880540
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer OncoGuia.
; Manchon Walsh P; Manchon P; Borràs JM; Ferro T; Espinàs JA
Clin Transl Oncol; 2009 Dec; 11(12):805-24. PubMed ID: 20045787
[No Abstract] [Full Text] [Related]
8. Commentary on "Small cell lung cancer: time to diagnosis and treatment".
Hoehn D
South Med J; 2012 Aug; 105(8):424-5. PubMed ID: 22864100
[No Abstract] [Full Text] [Related]
9. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening feasibility in Australia.
Marshall HM; Bowman RV; Ayres J; Crossin J; Lau M; Slaughter RE; Redmond S; Passmore L; McCaul E; Courtney D; Leong SC; Windsor M; Zimmerman PV; Yang IA; Fong KM
Eur Respir J; 2015 Jun; 45(6):1734-7. PubMed ID: 25837038
[No Abstract] [Full Text] [Related]
11. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
12. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Park SY; Yoon JK; Park KJ; Lee SJ
Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the role of FDG-PET/CT in lung cancer management.
Al-Jahdali H; Khan AN; Loutfi S; Al-Harbi AS
J Infect Public Health; 2012 Dec; 5 Suppl 1():S35-40. PubMed ID: 23244185
[TBL] [Abstract][Full Text] [Related]
14. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1087-92. PubMed ID: 15052206
[TBL] [Abstract][Full Text] [Related]
15. [Non-small cell lung cancer: evaluation of node and metastatic staging].
Brauner M; Brillet PY
Rev Pneumol Clin; 2008 Oct; 64(5):245-9. PubMed ID: 18995154
[No Abstract] [Full Text] [Related]
16. The utility of fine-needle aspiration in the diagnosis of primary and metastatic tumors to the lung: a retrospective examination of 1,032 cases.
Adams J; Wu HH
Acta Cytol; 2012; 56(6):590-5. PubMed ID: 23207436
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic accuracy and significance of cytopathology in lung cancer].
Wang HP; Zhang L; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):726-8. PubMed ID: 24447547
[No Abstract] [Full Text] [Related]
18. The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.
Werner L; Keller FA; Bhure U; Roos JE; Tornquist K; Del Sol Pèrez-Lago M; Gautschi O; Strobel K
BMC Med Imaging; 2017 Jul; 17(1):41. PubMed ID: 28693444
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer detection by canine scent: will there be a lab in the lab?
McCulloch M; Turner K; Broffman M
Eur Respir J; 2012 Mar; 39(3):511-2. PubMed ID: 22379142
[No Abstract] [Full Text] [Related]
20. Conventional versus Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymph Adenopathies: A Randomized Controlled Trial.
Bonifazi M; Tramacere I; Zuccatosta L; Mei F; Sediari M; Paonessa MC; Gasparini S
Respiration; 2017; 94(2):216-223. PubMed ID: 28531883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
